News


27
Jan 10

FDASM

FDASM – “Everything about the FDA, Internet, & Social Media”

It’s an aggregator of information about the FDA, it’s use of social media, and it’s regulation of social media use by the industries it oversees.


15
Jan 10

Press Trust of India: Dedicated ‘pharma zone’ at IGI

Dedicated ‘pharma zone’ at IGI

The Indira Gandhi International airport here will soon have a dedicated zone for storing imported and exported pharma products in controlled atmosphere till Customs checking is conducted.

The first-of-its-kind ‘pharma zone’ will ensure maintenance of the quality of the drugs and products being transported.

The pharma companies will have to pay for using the facility.

Customs is enough of a concern without worrying about if your product is being compromised by the storage conditions.


13
Jan 10

Government Health IT: FDA launches online ‘transparency’ services

FDA launches online ‘transparency’ services

As part of the plan, FDA offer will Web-based videos about the agency’s tasks, such as how to find out if a drug is approved, and online forums where the public may question senior officials about how drugs and medical devices move to market. FDA will detail the services on its Web site.

The transparency project is part of the Obama administration’s Open Government Initiative, its plan to make federal agencies more accessible and to share information more widely. The FDA’s initiative is being led by Joshua Sharfstein, principal deputy FDA commissioner.


24
Nov 09

Eye on FDA: What We Didn’t Hear at the FDA Part 15 Meeting on Social Media

Eye on FDA: What We Didn’t Hear at the FDA Part 15 Meeting on Social Media

We heard from far too few pharma companies, and far too many bloggers.

What was missing? What anyone should be doing in the meantime, what’s the process going forward, and what (if anything) is going on in Europe.


28
Sep 09

World of DTC Marketing: Why social media integration doesn’t matter for DTC marketers

World of DTC Marketing: Why social media integration doesn’t matter for DTC marketers

Recently a friend of mine within the drug industry sent me the metrics for his website from his IT group. It consisted of 5 lines of data showing visitors, number of pages viewed and average number of visitors per day. When I asked him about more detailed data he responded with “that’s all I have”. Since this product is a $500 million drug I thought there would be more but this is one of the key reasons why pharma doesn’t get it and is not ready for the digital revolution.

Also…

It’s ironic that most pharma marketers won’t go to the bathroom with doing research yet when it comes to researching the development of online marketing they take a pass and usually the budget drives the strategy. Social media can be measured and those measurements can be translated in new Rx’s with data that is more believable than 5:1 ROI’s on TV spots. In order for web analytics to be meaningful they have to tell a story to marketers so that the lights go off and they ask “what if…”. The problem right now is that those lights are burned out and nobody wants to replace them.